Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
The FEBS Journal|August 20, 2010
Conformation-dependent hydride transfer in neuronal nitric oxide synthase reductase domainAndrew Welland, Simon DaffBiochemistry|August 23, 2008
Importance of the domain-domain interface to the catalytic action of the NO synthase reductase domainAndrew Welland, Pierre E Garnaud, Maki Kitamura, et al.European Urology|December 29, 2015
A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal OestradiolRuth E Langley, Howard G Kynaston, Abdulla A Alhasso, et al.Proceedings of the National Academy of Sciences of the United States of America|March 10, 2010
Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognitionAlex Theodossis, Carole Guillonneau, Andrew Welland, et al.Contemporary Clinical Trials|March 18, 2023
Healthcare systems data in the context of clinical trials - A comparison of cardiovascular data from a clinical trial dataset with routinely collected dataArchie Macnair, Matthew Nankivell, Macey L Murray, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 11, 2013
HLA peptide length preferences control CD8+ T cell responsesMelissa J Rist, Alex Theodossis, Nathan P Croft, et al.BJU International|October 19, 2016
Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancerDuncan C Gilbert, Trinh Duong, Howard G Kynaston, et al.Pageof 1